| Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma SK Daniel, KM Sullivan, KP Labadie, VG Pillarisetty Clinical and translational medicine 8, 1-17, 2019 | 188 | 2019 |
| Mobilization of CD8+ T Cells via CXCR4 Blockade Facilitates PD-1 Checkpoint Therapy in Human Pancreatic Cancer YD Seo, X Jiang, KM Sullivan, FG Jalikis, KS Smythe, A Abbasi, M Vignali, ... Clinical Cancer Research 25 (13), 3934-3945, 2019 | 175 | 2019 |
| Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases KM Sullivan, X Jiang, P Guha, C Lausted, JA Carter, C Hsu, KP Labadie, ... Gut 72 (2), 325-337, 2023 | 64 | 2023 |
| Neutrophil‐to‐lymphocyte ratio as a predictor of outcomes for patients with hepatocellular carcinoma: a Western perspective KM Sullivan, RT Groeschl, KK Turaga, S Tsai, KK Christians, SB White, ... Journal of surgical oncology 109 (2), 95-97, 2014 | 60 | 2014 |
| An acquired scaffolding function of the DNAJ-PKAc fusion contributes to oncogenic signaling in fibrolamellar carcinoma RE Turnham, FD Smith, HL Kenerson, MH Omar, M Golkowski, I Garcia, ... Elife 8, e44187, 2019 | 54 | 2019 |
| Tumor slice culture as a biologic surrogate of human cancer HL Kenerson, KM Sullivan, YD Seo, KM Stadeli, C Ussakli, X Yan, ... Annals of translational medicine 8 (4), 2020 | 47 | 2020 |
| Establishment of slice cultures as a tool to study the cancer immune microenvironment X Jiang, YD Seo, KM Sullivan, VG Pillarisetty Cancer Immunosurveillance: Methods and Protocols, 283-295, 2019 | 35 | 2019 |
| Precision oncology in liver cancer KM Sullivan, HL Kenerson, VG Pillarisetty, KJ Riehle, RS Yeung Annals of Translational Medicine 6 (14), 2018 | 26 | 2018 |
| Modulation of immune checkpoints by chemotherapy in human colorectal liver metastases N Jabbari, HL Kenerson, C Lausted, X Yan, C Meng, KM Sullivan, ... Cell Reports Medicine 1 (9), 2020 | 25 | 2020 |
| IWATE criteria are associated with perioperative outcomes in robotic hepatectomy: a retrospective review of 225 resections KP Labadie, DJ Droullard, AW Lois, SK Daniel, KE McNevin, JV Gonzalez, ... Surgical Endoscopy, 1-7, 2022 | 24 | 2022 |
| Protocol for tissue slice cultures from human solid tumors to study therapeutic response HL Kenerson, KM Sullivan, KP Labadie, VG Pillarisetty, RS Yeung STAR protocols 2 (2), 100574, 2021 | 24 | 2021 |
| Opioid use following bariatric surgery: results of a prospective survey AP Ehlers, KM Sullivan, KM Stadeli, JI Monu, JY Chen-Meekin, ... Obesity surgery 30, 1032-1037, 2020 | 13 | 2020 |
| Neurotensin as a source of cyclic AMP and co-mitogen in fibrolamellar hepatocellular carcinoma KJ Riehle, HL Kenerson, KM Riggle, R Turnham, K Sullivan, R Bauer, ... Oncotarget 10 (49), 5092, 2019 | 8 | 2019 |
| Glypican-3 targeted delivery of 89Zr and 90Y as a theranostic radionuclide platform for hepatocellular carcinoma KP Labadie, AD Ludwig, AL Lehnert, DK Hamlin, AL Kenoyer, ... Scientific Reports 11 (1), 3731, 2021 | 7 | 2021 |
| Road map for fibrolamellar carcinoma: progress and goals of a diversified approach ER Kastenhuber, J Craig, J Ramsey, KM Sullivan, J Sage, S de Oliveira, ... Journal of hepatocellular carcinoma, 41-48, 2019 | 6 | 2019 |
| Multivisceral resection in robotic liver surgery KM Sullivan, Y Fong Cancers 14 (2), 355, 2022 | 3 | 2022 |
| IL-10 blockade reactivates antitumor immunity in human colorectal cancer liver metastases KM Sullivan, X Jiang, YD Seo, HL Kenerson, X Yan, C Lausted, C Meng, ... Cancer Research 79 (13_Supplement), 4489-4489, 2019 | 3 | 2019 |
| Multicenter dose-escalation Phase I trial of mitomycin C pressurized intraperitoneal aerosolized chemotherapy in combination with systemic chemotherapy for appendiceal and … M Raoof, KM Sullivan, PH Frankel, M Fakih, TW Synold, D Lim, Y Woo, ... Pleura and Peritoneum 7 (4), 169-177, 2022 | 2 | 2022 |
| Dopamine secreting adrenal tumor—ganglioneuroma rather than pheochromocytoma: case report AJ Burns, KM Sullivan, EK Koh, MS Tretiakova, NK Zern Gland Surgery 9 (6), 2204, 2020 | 2 | 2020 |
| Novel M2 macrophage gene signature as a biomarker of poor outcomes independent of TNM stage in peritoneal liquid biopsy of gastric cancer patients KM Sullivan, H Li, K Mahuron, YC Yuan, J Chao, B Paz, H Han, Y Fong, ... Cancer Research 82 (12_Supplement), 6144-6144, 2022 | 1 | 2022 |
